Reproductive endocrinology

Growth patterns and bone maturation in children with sex chromosomal (45,X/46,XY) differences of sex development

Eur J EndocrinolPublished Retrospective cohort study

Authors' conclusion

Female growth charts and bone age readings best reflect longitudinal growth and maturation in individuals with 45,X/46,XY DSD and provide the most accurate prediction of nFH. Larger prospective studies are needed to guide evidence-based treatment decisions.

Study context

Population
Children with 45,X/46,XY mosaicism DSD, 26 centres54 with longitudinal data
Participants
95 children
Exposure
Group 1 vs Group 2
Outcome
Mean height SDS, bone age (Greulich and Pyle), PAH, TH and nFH
Methodological detailsmulticentre, registry-based
  • Multicentre
  • Registry-based

Main finding

As reported in the abstract

Near-final height (nFH)
GroupValueNear-final height (nFH) SD score (SDS), female chartsnFH SDS, male charts
Group 1mean 157.5 cm−0.7−2.0
Group 2mean 160.3 cm−0.3−1.6

Value

Group 1mean 157.5 cm
Group 2mean 160.3 cm

Near-final height (nFH) SD score (SDS), female charts

Group 1−0.7
Group 2−0.3

nFH SDS, male charts

Group 1−2.0
Group 2−1.6
  • Between Group 1 and Group 2: n.s. — n.s.

Observational data: associations, not effects.

Further findings

Bone age

Bone age delayed using female standards and advanced using male standards

Height prediction

Female-based predicted adult height (PAH) slightly underestimated nFH; male-based PAH slightly overestimated it
PAH approximated nFH more accurately than target height (TH)

nFH by growth hormone (GH) treatment

nFH similar with and without GH treatment
  • Interpretation limited by small sample size and treatment bias

Original publication

Growth patterns and bone maturation in children with sex chromosomal (45,X/46,XY) differences of sex development. Eur J Endocrinol. Published 19 May 2026. doi:10.1093/ejendo/lvag092

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.